维拉帕米盐酸盐结构式
|
常用名 | 维拉帕米盐酸盐 | 英文名 | Verapamil hydrochloride |
|---|---|---|---|---|
| CAS号 | 23313-68-0 | 分子量 | 491.063 | |
| 密度 | N/A | 沸点 | 586.1ºC at 760 mmHg | |
| 分子式 | C27H39ClN2O4 | 熔点 | 140-144ºC | |
| MSDS | N/A | 闪点 | 308.3ºC |
维拉帕米盐酸盐用途【用途一】 用于有机合成、医药工业;主要用于阵发性室上性心动过速,也用于心绞痛、高血压和肥厚型梗塞性心肌病 |
| 中文名 | 盐酸维拉帕米 |
|---|---|
| 英文名 | Verapamil Hydrochloride |
| 中文别名 | 5-((3,4-二甲氧基苯乙基)(甲基)氨基)-2-(3,4-二甲氧基苯基)-2-异丙基戊腈 | 异搏停 盐酸盐 | 维拉帕米盐酸盐 |
| 英文别名 | 更多 |
| 沸点 | 586.1ºC at 760 mmHg |
|---|---|
| 熔点 | 140-144ºC |
| 分子式 | C27H39ClN2O4 |
| 分子量 | 491.063 |
| 闪点 | 308.3ºC |
| 精确质量 | 490.259827 |
| PSA | 63.95000 |
| LogP | 5.89508 |
| 外观性状 | powder | white |
| 蒸汽压 | 1.01E-13mmHg at 25°C |
| 储存条件 | 0-6°C |
| 水溶解性 | methanol: 50 mg/mL, clear, colorless |
| 危害码 (欧洲) | T:Toxic; |
|---|---|
| 风险声明 (欧洲) | R23/24/25 |
| 安全声明 (欧洲) | S36/37/39-S45 |
| 危险品运输编码 | UN 2811 6.1/PG 3 |
| WGK德国 | 3 |
| RTECS号 | YV8320000 |
| 海关编码 | 2926909090 |
|
~%
维拉帕米盐酸盐 23313-68-0 |
| 文献:US2009/171110 A1, ; Page/Page column 6 ; |
|
~%
维拉帕米盐酸盐 23313-68-0 |
| 文献:US4350636 A1, ; |
| 维拉帕米盐酸盐上游产品 3 | |
|---|---|
| 维拉帕米盐酸盐下游产品 0 | |
| 海关编码 | 2926909090 |
|---|---|
| 中文概述 | 2926909090 其他腈基化合物. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | HS:2926909090 other nitrile-function compounds VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
| 2-(3,4-Dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(1-methylethyl)pentanonitrilhydrochlorid |
| 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(1-methylethyl)pentanenitrile hydrochloride |
| Izoptin Hydrochloride |
| Benzeneacetonitrile, α-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)-, hydrochloride (1:1) |
| MFCD00055208 |
| (±)-Verapamil hydrochloride |
| 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile hydrochloride (1:1) |
| Verogalid ER |
| 2-(3,4-Dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-isopropylpentanenitrile hydrochloride |
| a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-(1-methylethyl)benzeneacetonitrile Monohydrochloride |
| Verapamil Hydrochloride (Isoptin, Iproveratril, Calan) |
| 5-[(3,4-dimethoxyphenethyl)(methyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile hydrochloride |
| 4-cyano-4-(3,4-dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-N,5-dimethylhexan-1-aminium chloride |
| benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-, hydrochloride (1:1) |
| verapamil hydrochloride |
| benzeneacetonitrile, α-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)-, monohydrochloride |
| dl-Verapamil Hydrochloride |
| 2-(3,4-diméthoxyphényl)-5-{[2-(3,4-diméthoxyphényl)éthyl](méthyl)amino}-2-(1-méthyléthyl)pentanenitrile chlorhydrate |
| 2-(3,4-Dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-isopropylpentanenitrile hydrochloride (1:1) |
| Veraptin |
| Arpamyl |
| Veracim |
| Vasolan |
| Verexamil |
| Drosteakard |
| EINECS 245-579-2 |
| Lekoptin Retard |